GlassScriptPhysician profile
Earl E Ferguson
NPI 1851371827
$37,738.69
in general payments reported to CMS, 2019-2025
38 companies · $1,594 in 2025
The $1,594 reported for 2025 was more than what 81% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,057 · 2021: $4,912 · 2022: $3,984 · 2023: $11K · 2024: $1,349 · 2025: $1,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,800 · Food and Beverage: $5,331 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,800.00 |
| Food and Beverage | $5,331.09 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $19,228.08 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $11,006.86 | 2019-2022 | |
| Next Science LLC | $1,286.46 | 2023 | Xperience, Blastx, Surgx |
| Merz North America, INC. | $1,093.74 | 2019-2023 | Xeomin |
| Integra Lifesciences Corporation | $720.96 | 2025 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Musculoskeletal Transplant Foundation INC. | $564.77 | 2019-2025 | |
| Janssen Biotech, INC. | $418.68 | 2019-2023 | Tremfya |
| Kerecis Limited | $379.61 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Davol INC. | $357.04 | 2021-2022 | |
| Innovation Technologies INC | $347.93 | 2024-2025 | Irrisept |
| Misonix INC | $294.69 | 2019-2021 | |
| Abbvie INC. | $203.77 | 2023-2024 | |
| Galderma Laboratories, L.P. | $200.87 | 2019-2025 | Dysport |
| Elutia, INC. | $185.57 | 2021 | |
| Mentor Worldwide LLC | $153.88 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $146.72 | 2019-2023 | Olumiant, Taltz |
| Almirall LLC | $131.56 | 2019-2022 | |
| Mimedx Group, INC. | $125.16 | 2025 | |
| Heron Therapeutics, INC. | $125.00 | 2025 | Zynrelef |
| Incyte Corporation | $119.66 | 2021-2023 | Opzelura |
| Vyne Pharmaceuticals INC. | $96.06 | 2020-2021 | |
| Revance Therapeutics, INC. | $66.67 | 2024-2025 | Daxxify |
| Biofrontera INC. | $53.67 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Acera Surgical, INC. | $51.36 | 2020-2022 | |
| Leo Pharma INC. | $50.64 | 2022 | |
| Journey Medical Corporation | $41.56 | 2020-2022 | |
| Amgen INC. | $35.63 | 2021-2023 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.17 | 2022 | |
| Celgene Corporation | $30.87 | 2019 | |
| Genzyme Corporation | $27.10 | 2022 | |
| Sun Pharmaceutical Industries INC. | $25.66 | 2023 | Ilumya |
| Motiva USA, LLC | $24.63 | 2024 | |
| Medtronic, INC. | $21.20 | 2021 | |
| Bioventus LLC | $20.65 | 2023 | |
| Smith+Nephew, INC. | $20.11 | 2020 | |
| Aclaris Therapeutics, INC. | $18.75 | 2019 | |
| Mayne Pharma Commercial LLC | $17.08 | 2019 | |
| Sientra, INC. | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Earl Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.